About 500 reports
- Global Cardiovascular Drugs Market, Historic and Forecast, Split By Segment, 2012 - 2020
- PERSONALIZED MEDICINE FOR TREATMENT OF CARDIOVASCULAR DISORDERS
Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth
- CARDIOVASCULAR DISEASE THERAPEUTICS MARKET, GLOBAL, PIPELINE FOR CARDIOVASCULAR...
- A) Global cardiovascular disease market split
Blood Flow Measurement Devices Market by Product, Laser Doppler), Application, Non-invasive ) - Global Forecast to 2021
- CARDIOVASCULAR DISEASE SEGMENT TO ACCOUNT FOR THE LARGEST
- CARDIOVASCULAR DISEASE APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis
- 5.3.1 Cardiovascular Disease
- Cardiovascular Disease Therapeutics Market, Global,
- CARDIAC PACEMAKERS MARKET IN AMERICAS
In the UK, hospital admission for cardiovascular diseases increased due to increased cardiovascular disease prescriptions and operations over the last few decades making it second leading cause of death in the year 2014.
- Radiofrequency ablation market in EMEA 2016-2021 ($ millions)
- RADIOFREQUENCY ABLATION MARKET IN EMEA
In 2014, Europe recorded four million deaths related to cardiovascular diseases.
- TOTAL NUMBER OF HOSPITALS IN US
- LIST OF ABBREVIATIONS
Cardiovascular diseases accounts for highest patient pool in the country, after HIV/ AIDS.
- EP DIAGNOSTIC CATHETERS MARKET IN AMERICAS
- GLOBAL ADVANCED EP DIAGNOSTIC CATHETERS MARKET
India: Treatment of chronic disorders such as cardiovascular diseases in ASCs is a growing trend in India.
- 3.3 FACTORS INFLUENCING MARKET
In cardiovascular diseases ablation finds its application mainly in atrial fibrillation and tachycardia.
- GLOBAL ENDOVASCULAR GRAFTS MARKET
The leading cause behind the worldwide deaths is CVDs Cardiovascular disease, the common conditions associated with it is stenosis or occlusion of blood vessels.
- 6.1.1 GROWING AGING POPULATION
Aging population are more prone to coagulation disorders, cardiovascular disease and surgeries such as knee and hip replacement surgeries.
- Description and impact on the market
- KEY MARKET HIGHLIGHTS
High cholesterol levels can cause cardiovascular diseases (CVD) such as stroke and atherosclerosis.
- Partnership agreements...
In May 2016, MyoKardia' s MYK-##, a novel drug therapy targeting genetic cardiovascular disease (CVD), received the orphan drug designation by the US FDA, for the treatment of symptomatic obstructive HCM.
Currently, MI drug eluting balloons are used for the treatment of cardiovascular diseases (CVDs) and represent lower risks compared with conventional procedures.
- Incidences of Cardiovascular Diseases
- PERCENTAGE OF POPULATION SUFFERING FROM CARDIOVASCULAR DISEASE IN USA (2009-2012)
cardiovascular disease CVD - electrocardiogram EKG - European Union EU - Food and Drug Administration FDA - low density lipoprotein - LDL NSTEMI - - STEMI non-ST segment elevation myocardial infarction ST segment elevation myocardial infarction PART ##: Explore Technavio Our team of ## spe
- KEY CLINICAL TRIALS ASSESSING OTHER INDICATIONS FOR RENAL DENERVATION
- Unmet Needs
CARDIOVASCULAR DISEASES (CVDS), FACT SHEET NO##.
- PROVIDES THE PRODUCT PROFILE FOR PRALUENT.
- RISK FACTORS AND COMORBIDITIES FOR ACS
CHAPTER ##: CARDIOVASCULAR DISEASE.
cardio vascular diseases computed tomography electrocardiogram European Union minimally invasive NCBI NHLBI NIH R& D USB National Center for Biotechnology Information National Heart, Lung, and Blood Institute National Institutes of Health research and development universal serial bus PAR